Delays in receipt of neoadjuvant chemotherapy compared to upfront surgery in patients with operable breast cancer

被引：0
|
作者：
Wooster, Margaux
DeStephano, David
Beauchemin, Melissa
Wang, Shikun
Hur, Chin
Wright, Jason Dennis
Hershman, Dawn L.
Accordino, Melissa Kate
机构：
[1] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[2] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[3] Columbia Univ, Irving Med Ctr, New York, NY USA
[4] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[5] Columbia Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Vagelos Coll Phys & Surg, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13561
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Factors associated with delays in receipt of neoadjuvant chemotherapy in patients with operable breast cancer.
    Wooster, Margaux
    DeStephano, David
    Beauchemin, Melissa
    Wang, Shikun
    Hur, Chin
    Wright, Jason Dennis
    Hershman, Dawn L.
    Accordino, Melissa Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer
    Franceschini, Gianluca
    Di Leone, Alba
    Natale, Maria
    Sanchez, Martin Aleandro
    Masett, Riccardo
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (03) : 290 - 290
  • [3] Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients
    Omarini, C.
    Guaitoli, G.
    Noventa, S.
    Andreotti, A.
    Gambini, A.
    Palma, E.
    Papi, S.
    Tazzioli, G.
    Balduzzi, S.
    Dominici, M.
    Cascinu, S.
    Piacentini, F.
    EJSO, 2017, 43 (04): : 613 - 618
  • [4] Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer
    Piacentini, F.
    Filieri, M. E.
    Grizzi, G.
    Omarini, C.
    Maur, M.
    Guaitoli, G.
    Tazzioli, G.
    Madrigali, S.
    Caggia, F.
    Luppi, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 4 - 5
  • [5] Neoadjuvant chemotherapy for operable breast cancer
    Mieog, J. S. D.
    van der Hage, J. A.
    de Velde, C. J. H. van
    BRITISH JOURNAL OF SURGERY, 2007, 94 (10) : 1189 - 1200
  • [6] Neoadjuvant chemotherapy in operable breast cancer
    Giardina, G
    Chini, C
    Fagnoni, E
    Pigni, A
    Membrini, F
    Masera, LR
    Proserpio, I
    Martinelli, B
    Pinotti, G
    ANNALS OF ONCOLOGY, 2000, 11 : 44 - 44
  • [7] Multiagent Neoadjuvant Chemotherapy Compared to Upfront Surgery in Pancreatic Cancer of the Body and Tail
    Franklin, Oskar
    Sugawara, Toshitaka
    Franco, Salvador Rodriguez
    Schulick, Richard
    Del Chiaro, Marco
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S156 - S156
  • [8] Locoregional recurrence and survival of breast-conserving surgery compared to mastectomy following neoadjuvant chemotherapy in operable breast cancer
    Lv, Fa-you
    Mo, Zongming
    Chen, Binjie
    Huang, Zhen
    Mo, Qinguo
    Tan, Qixing
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Neoadjuvant chemotherapy in operable breast cancer: The pros
    Mamounas, Eleftheriors R.
    BREAST CARE, 2006, 1 (06) : 348 - 351
  • [10] NEOADJUVANT CHEMOTHERAPY IN OPERABLE BREAST-CANCER
    SCHOLL, SM
    ASSELAIN, B
    PALANGIE, T
    DORVAL, T
    JOUVE, M
    GIRALT, EG
    VILCOQ, J
    DURAND, JC
    POUILLART, P
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1668 - 1671
12345